While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

While weight loss medications can deliver significant results, our bodies eventually adapt to everything. And many people end ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

Novo Nordisk’s SOUL trial confirms that oral semaglutide significantly reduces the risk of heart attack, stroke, and ...

Emergency room visits attributed to popular weight loss drugs such as Ozempic and Wegovy remain quite rare overall, but do ...

Skinny jab? Try skinny juice. For centuries, it’s been enjoyed by people in South America — and it’s long been linked to ...

A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...

Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...